Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
AI
Tech
Science

Eli Lilly
Pharmaceuticals
Novo Nordisk
Ozempic
Mounjaro
GSK
Novartis
Sanofi
Amycretin
Topics

Advertisement

Advertisement

Eli Lilly

Share

Top Latest Popular

Novo Nordisk hikes 2026 outlook again RTE 3d

RTE 3d

Novo Nordisk Ozempic

Hims & Hers rises 5% as Eli Lilly deal brings $149 obesity pill access Proactive Investors (US) 1d

Proactive Investors (US) 1d

Lilly’s retatrutide beats Ozempic in head-to-head trial Clinical Trials Arena 09:41 Thu, 29 Oct

Clinical Trials Arena 09:41 Thu, 29 Oct

Novo Nordisk Ozempic

Advertisement

Advertisement

Eli Lilly’s tirzepatide outperforms big pharma companies in Q3 Pharmaceutical Technology 11:20 Fri, 30 Oct

Pharmaceutical Technology 11:20 Fri, 30 Oct

Mounjaro Tirzepatide

Peegs.com sources: IU adds "significant" Eli Lilly sponsorship, Lilly logo to be added to Assembly Hall floor InsideIndiana 12:31 Fri, 30 Oct

InsideIndiana 12:31 Fri, 30 Oct

NCAA Basketball Pharma

Big Ten Basketball

Eli Lilly just delivered another blowout quarter. Is this unstoppable Growth Stock still a buy? The Motley Fool 5d

The Motley Fool 5d

Mounjaro Pharma

Advertisement

Advertisement

Latest

In the last 2 hours

Hims Partnership Could Be A Big Deal For Eli Lilly (LLY) Simply Wall St 19:24

Eli Lilly Just Raised Its 2026 Revenue Forecast by $5.5 Billion. Is the Stock Still a Buy? The Motley Fool 18:58

Earlier Today

Eli Lilly Is Much More Than a Weight-Loss Drug Company. Here's the Evidence The Motley Fool 00:40

Yesterday

Eli Lilly (LLY) Widens Access To Its Obesity Drugs Through Telehealth Simply Wall St 18:28 Fri, 06 Nov

Hims & Hers rises 5% as Eli Lilly deal brings $149 obesity pill access Proactive Investors (US) 17:40 Fri, 06 Nov

Lilly partners with Hims & Hers on obesity drug sales pharmaphorum 13:22 Fri, 06 Nov

Lilly, Hims & Hers Partner To Expand Access To Weight-Loss Medicines; Stock Up RTT News 12:47 Fri, 06 Nov

Mounjaro maker launches High Court action to block counterfeit drug sites City AM 11:56 Fri, 06 Nov

Lilly and Hims & Hers expand access to FDA-approved Lilly medicines Business Wire (Press Release) 11:47 Fri, 06 Nov

Thursday

4 Healthcare ETFs to Tap Into Eli Lilly's Post-Q3 Earnings Rally Zacks 20:02 Thu, 05 Nov

Advertisement

Advertisement

Advertisement

Advertisement

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis